Harmony Biosciences names Peter Anastasiou president and CEO effective Jan. 1, 2027

HRMY•2026-11-04

Harmony Biosciences named Peter Anastasiou president and CEO effective Jan. 1, 2027; he will succeed Jeffrey Dayno, who retires Dec. 31, 2026.

1. Leadership transition

Harmony Biosciences named Peter Anastasiou president and CEO effective Jan. 1, 2027. Anastasiou is currently senior executive vice president and chief operating officer; he will succeed Jeffrey Dayno, who retires Dec. 31, 2026.

Harmony Biosciences names Peter Anastasiou president and CEO effective Jan. 1, 2027

1. Leadership transition

Related News

Polar Power targets approximately $2 million in total annualized savings

Marqeta participates in Citi and UBS investor conferences

Medline Q3 2026 adjusted EBITDA rises 12% to $960 million

Nomad Foods management says pricing, stable volumes drive Q3 2026 organic revenue growth of 1.6%

Harmony Biosciences Q3 revenue misses estimates, profit falls on royalty charges